Immunome Inc. (IMNM) — Institutional Holders, Q2 2026
204 institutional investment managers reported a IMNM position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $2.5B. Every filer is listed below, ranked by position value, 100 per page; this page shows ranks 1 to 100. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.
IMNM in Q2 2026: what funds did
Funds that filed a 13F for both Q1 2026 and Q2 2026, by what they did with the common stock. Share counts are adjusted for any split between the two quarters; dollar figures are the change in shares at this quarter’s price.
Biggest buyers
- T. Rowe Price Investment ManagementAdded · +3,312,872 sh+$70.2M
- MetLife Investment ManagementAdded · +803,219 sh+$17.0M
- BlackRockAdded · +636,818 sh+$13.5M
- WELLINGTON MANAGEMENT GROUP LLPAdded · +478,239 sh+$10.1M
- GOLDMAN SACHS GROUPAdded · +411,013 sh+$8.7M
Biggest sellers
- LEUCADIA NATIONALSold out · -1,160,715 sh-$24.6M
- PRICE T ROWE ASSOCIATESTrimmed · -1,085,634 sh-$23.0M
- MARSHALL WACE, LLPTrimmed · -980,251 sh-$20.8M
- JPMORGAN CHASETrimmed · -929,288 sh-$19.7M
- Polar Capital PlcSold out · -849,479 sh-$18.0M
IMNM 13F holders ranked 1–100 of 204
| # | Institution | Shares | Value | % of portfolio | QoQShares vs Q1 2026 |
|---|---|---|---|---|---|
| 1 | T. Rowe Price Investment Management#1 · 19,676,883 sh | 19,676,883 | $417.0M | 0.27% | +20.2% |
| 2 | FMR#2 · 16,987,553 sh | 16,987,553 | $360.0M | 0.02% | +0.1% |
| 3 | BlackRock#3 · 8,805,492 sh | 8,805,492 | $186.6M | <0.01% | +7.8% |
| 4 | STATE STREET#4 · 5,494,625 sh | 5,494,625 | $116.4M | <0.01% | +1.8% |
| 5 | WELLINGTON MANAGEMENT GROUP LLP#5 · 5,210,216 sh | 5,210,216 | $110.4M | 0.02% | +10.1% |
| 6 | Redmile Group#6 · 4,911,590 sh | 4,911,590 | $104.1M | 6.99% | -11.6% |
| 7 | PRIMECAP MANAGEMENT#7 · 4,581,431 sh | 4,581,431 | $97.1M | 0.06% | -4.3% |
| 8 | VANGUARD CAPITAL MANAGEMENT#8 · 4,551,289 sh | 4,551,289 | $96.4M | <0.01% | +2.7% |
| 9 | DRIEHAUS CAPITAL MANAGEMENT#9 · 4,346,139 sh | 4,346,139 | $92.1M | 0.53% | +6.0% |
| 10 | Enavate Sciences GP#10 · 3,613,799 sh | 3,613,799 | $76.6M | 22.17% | 0.0% |
| 11 | GEODE CAPITAL MANAGEMENT#11 · 2,754,889 sh | 2,754,889 | $58.4M | <0.01% | +7.6% |
| 12 | MORGAN STANLEY#12 · 2,407,942 sh | 2,407,942 | $51.0M | <0.01% | -15.3% |
| 13 | SILVERARC CAPITAL MANAGEMENT#13 · 2,017,009 sh | 2,017,009 | $42.7M | 4.44% | +9.0% |
| 14 | JPMORGAN CHASE#14 · 1,848,548 sh | 1,848,548 | $39.0M | <0.01% | -33.5% |
| 15 | PRICE T ROWE ASSOCIATES#15 · 1,773,229 sh | 1,773,229 | $37.6M | <0.01% | -38.0% |
| 16 | Sofinnova Ventures#16 · 1,720,316 sh | 1,720,316 | $36.5M | 1.88% | +1.1% |
| 17 | READYSTATE ASSET MANAGEMENT#17 · 1,605,820 sh | 1,605,820 | $34.0M | 0.02% | +23.3% |
| 18 | GOLDMAN SACHS GROUP#18 · 1,512,489 sh | 1,512,489 | $32.0M | <0.01% | +37.3% |
| 19 | VANGUARD PORTFOLIO MANAGEMENT#19 · 1,348,979 sh | 1,348,979 | $28.6M | <0.01% | +34.0% |
| 20 | PRINCIPAL FINANCIAL GROUP#20 · 1,347,358 sh | 1,347,358 | $28.6M | 0.01% | -2.1% |
| 21 | BNP Paribas Asset Management Holding S.A.#21 · 1,250,275 sh | 1,250,275 | $26.5M | 0.03% | +13.9% |
| 22 | Woodline Partners#22 · 1,000,398 sh | 1,000,398 | $21.2M | 0.07% | -36.5% |
| 23 | NORTHERN#23 · 968,346 sh | 968,346 | $20.5M | <0.01% | +7.7% |
| 24 | CHARLES SCHWAB INVESTMENT MANAGEMENT#24 · 886,193 sh | 886,193 | $18.8M | <0.01% | +4.0% |
| 25 | MetLife Investment Management#25 · 859,076 sh | 859,076 | $18.2M | 0.08% | +1438.0% |
| 26 | VANGUARD FIDUCIARY#26 · 756,297 sh | 756,297 | $16.0M | <0.01% | +5.6% |
| 27 | Pivotal bioVenture Partners Investment Advisor#27 · 732,512 sh | 732,512 | $15.5M | 5.04% | 0.0% |
| 28 | TD ASSET MANAGEMENT#28 · 719,272 sh | 719,272 | $15.2M | 0.01% | +3.5% |
| 29 | NAN FUNG TRINITY (HK) Ltd#29 · 714,553 sh | 714,553 | $15.1M | 1.50% | 0.0% |
| 30 | Candriam S.C.A.#30 · 680,132 sh | 680,132 | $14.4M | 0.06% | +26.0% |
| 31 | BANK OF AMERICA#31 · 647,888 sh | 647,888 | $13.7M | <0.01% | -17.1% |
| 32 | Parkman Healthcare Partners#32 · 594,202 sh | 594,202 | $12.6M | 1.29% | +47.3% |
| 33 | MARSHALL WACE, LLP#33 · 500,537 sh | 500,537 | $10.6M | <0.01% | -66.2% |
| 34 | Qube Research & Technologies Ltd#34 · 439,186 sh | 439,186 | $9.3M | <0.01% | +133.3% |
| 35 | ALERUS FINANCIAL NA#35 · 383,421 sh | 383,421 | $8.1M | 0.36% | New |
| 36 | Granahan Investment Management#36 · 378,542 sh | 378,542 | $8.0M | 0.29% | +23.3% |
| 37 | DIMENSIONAL FUND ADVISORS#37 · 367,967 sh | 367,967 | $7.8M | <0.01% | +1001.4% |
| 38 | BNP PARIBAS FINANCIAL MARKETS#38 · 359,780 sh | 359,780 | $7.6M | <0.01% | -0.8% |
| 39 | Rock Springs Capital Management#39 · 347,666 sh | 347,666 | $7.4M | 0.36% | 0.0% |
| 40 | UBS Group AG#40 · 328,493 sh | 328,493 | $7.0M | <0.01% | -24.1% |
| 41 | Bank of New York Mellon#41 · 298,866 sh | 298,866 | $6.3M | <0.01% | +8.3% |
| 42 | Atom Investors#42 · 297,489 sh | 297,489 | $6.3M | 0.56% | -3.1% |
| 43 | Nuveen#43 · 288,922 sh | 288,922 | $6.1M | <0.01% | -5.4% |
| 44 | KENNEDY CAPITAL MANAGEMENT#44 · 277,064 sh | 277,064 | $5.9M | 0.10% | -3.5% |
| 45 | Toroso Investments#45 · 268,167 sh | 268,167 | $5.7M | <0.01% | -2.8% |
| 46 | TEMA ETFS#46 · 268,167 sh | 268,167 | $5.7M | — | -2.8% |
| 47 | Atika Capital Management#47 · 262,900 sh | 262,900 | $5.6M | 0.37% | 0.0% |
| 48 | FIRST ADVISORS#48 · 262,823 sh | 262,823 | $5.6M | <0.01% | New |
| 49 | RENAISSANCE TECHNOLOGIES#49 · 251,102 sh | 251,102 | $5.3M | <0.01% | +264.4% |
| 50 | Universal- Beteiligungs- und Servicegesellschaft mbH#50 · 231,861 sh | 231,861 | $4.9M | <0.01% | +0.5% |
| 51 | CITADEL ADVISORS#51 · 224,079 sh | 224,079 | $4.7M | <0.01% | +179.4% |
| 52 | Burkehill Global Management#52 · 200,000 sh | 200,000 | $4.2M | 0.15% | 0.0% |
| 53 | UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AME#53 · 188,636 sh | 188,636 | $4.0M | <0.01% | +0.9% |
| 54 | Swiss National Bank#54 · 181,600 sh | 181,600 | $3.8M | <0.01% | -1.8% |
| 55 | MANUFACTURERS LIFE INSURANCE COMPANY, THE#55 · 172,893 sh | 172,893 | $3.7M | <0.01% | -16.4% |
| 56 | GILDER GAGNON HOWE#56 · 152,265 sh | 152,265 | $3.2M | 0.03% | -10.0% |
| 57 | CITIGROUP#57 · 142,201 sh | 142,201 | $3.0M | <0.01% | +447.9% |
| 58 | FEDERATED HERMES#58 · 142,097 sh | 142,097 | $3.0M | <0.01% | New |
| 59 | ALLIANCEBERNSTEIN L.P.#59 · 133,500 sh | 133,500 | $2.9M | <0.01% | -18.3% |
| 60 | NOMURA ASSET MANAGEMENT INTERNATIONAL#60 · 135,451 sh | 135,451 | $2.9M | <0.01% | +39.4% |
| 61 | AMERIPRISE FINANCIAL#61 · 132,906 sh | 132,906 | $2.8M | <0.01% | +2.6% |
| 62 | RHUMBLINE ADVISERS#62 · 132,479 sh | 132,479 | $2.8M | <0.01% | +9.6% |
| 63 | Schonfeld Strategic Advisors#63 · 132,091 sh | 132,091 | $2.8M | 0.01% | +111.6% |
| 64 | XTX Topco Ltd#64 · 126,648 sh | 126,648 | $2.7M | 0.03% | +109.3% |
| 65 | Sio Capital Management#65 · 124,168 sh | 124,168 | $2.6M | 0.44% | -24.8% |
| 66 | Aristotle Atlantic Partners#66 · 122,675 sh | 122,675 | $2.6M | 0.11% | -1.9% |
| 67 | ALPS ADVISORS#67 · 114,440 sh | 114,440 | $2.4M | 0.01% | New |
| 68 | DEUTSCHE BANK AG\#68 · 111,593 sh | 111,593 | $2.4M | <0.01% | +25.2% |
| 69 | WELLS FARGO & COMPANY#69 · 101,394 sh | 101,394 | $2.1M | <0.01% | +142.8% |
| 70 | Legal & General Group Plc#70 · 89,623 sh | 89,623 | $1.9M | <0.01% | +9.8% |
| 71 | Trexquant Investment#71 · 88,391 sh | 88,391 | $1.9M | 0.01% | -47.0% |
| 72 | BIT Capital GmbH#72 · 83,400 sh | 83,400 | $1.8M | 0.05% | New |
| 73 | Rafferty Asset Management#73 · 83,170 sh | 83,170 | $1.8M | <0.01% | -46.8% |
| 74 | Neo Ivy Capital Management#74 · 80,876 sh | 80,876 | $1.7M | 0.39% | New |
| 75 | Cerity Partners#75 · 77,561 sh | 77,561 | $1.6M | <0.01% | -7.2% |
| 76 | Susquehanna Portfolio Strategies#76 · 74,324 sh | 74,324 | $1.6M | 0.03% | +68.3% |
| 77 | Edgestream Partners, L.P.#77 · 71,885 sh | 71,885 | $1.5M | 0.05% | +20.0% |
| 78 | Invesco Ltd.#78 · 68,938 sh | 68,938 | $1.5M | <0.01% | +3.6% |
| 79 | VANGUARD ASSET MANAGEMENT, Ltd#79 · 66,730 sh | 66,730 | $1.4M | <0.01% | +12.3% |
| 80 | SEI INVESTMENTS#80 · 62,483 sh | 62,483 | $1.3M | <0.01% | +18.4% |
| 81 | Freestone Capital#81 · 60,589 sh | 60,589 | $1.3M | 0.03% | -1.5% |
| 82 | CAPTRUST FINANCIAL ADVISORS#82 · 60,046 sh | 60,046 | $1.3M | <0.01% | New |
| 83 | Ikarian Capital#83 · 60,000 sh | 60,000 | $1.3M | 0.14% | New |
| 84 | SummitTX Capital, L.P.#84 · 59,476 sh | 59,476 | $1.3M | 0.03% | -36.0% |
| 85 | FRANKLIN RESOURCES#85 · 58,998 sh | 58,998 | $1.3M | <0.01% | +63.8% |
| 86 | MIRAE ASSET GLOBAL ETFS Ltd.#86 · 58,200 sh | 58,200 | $1.2M | <0.01% | -1.3% |
| 87 | Zurcher Kantonalbank (Zurich Cantonalbank)#87 · 57,673 sh | 57,673 | $1.2M | <0.01% | +29.6% |
| 88 | BAKER BROS. ADVISORS#88 · 55,306 sh | 55,306 | $1.2M | <0.01% | New |
| 89 | VIRGINIA RETIREMENT SYSTEMS ET Al#89 · 54,400 sh | 54,400 | $1.2M | <0.01% | +438.6% |
| 90 | Erste Asset Management GmbH#90 · 52,000 sh | 52,000 | $1.1M | <0.01% | 0.0% |
| 91 | Birchview Capital#91 · 50,000 sh | 50,000 | $1.1M | 0.50% | 0.0% |
| 92 | Lido Advisors#92 · 49,341 sh | 49,341 | $1.0M | <0.01% | +0.8% |
| 93 | Vanguard Global Advisers#93 · 49,084 sh | 49,084 | $1.0M | <0.01% | -2.2% |
| 94 | VICTORY CAPITAL MANAGEMENT#94 · 47,524 sh | 47,524 | $1.0M | <0.01% | +0.3% |
| 95 | NISA INVESTMENT ADVISORS#95 · 47,227 sh | 47,227 | $1.0M | — | -1.5% |
| 96 | Jupiter Topco#96 · 45,900 sh | 45,900 | $972.9K | <0.01% | — |
| 97 | STATE OF WISCONSIN INVESTMENT BOARD#97 · 45,443 sh | 45,443 | $962.9K | <0.01% | -7.2% |
| 98 | Mitsubishi UFJ Asset Management (UK) Ltd.#98 · 45,000 sh | 45,000 | $954.0K | — | +462.5% |
| 99 | SCHARF INVESTMENTS#99 · 44,389 sh | 44,389 | $940.6K | 0.03% | 0.0% |
| 100 | Corient Private Wealth#100 · 43,227 sh | 43,227 | $916.0K | <0.01% | -0.6% |
Funds that sold out of IMNM in Q2 2026 (28)
Held IMNM at the end of Q1 2026 and filed a Q2 2026 13F without it. Not in the list above, because they no longer hold it. Largest prior position first.
Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.